$bxrx and $grom had offerings and are up nicely today.

$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.

Probably get a bonus this year for all the fine work she's done with reverse splits and offerings.

Remember that we are ultimately at the beginning of commercialization and quite possible the safest spot to be with the current facts on our superior Briumvi treatment and best pricing for market share penetration.

$TGTX makes a lot of sense to do a 300M offering here imo

What stuck out was the combined value proposition: efficacy, safety, convenience, marketability, pricing, etc.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.

The BLA within days will send this well past our $6.00 offering price towards $7-$8.

$BLUE Thanks for offering sympathy & positive hope Mr. @BenKaitz.

$BLUE added more under offering

$BLUE You have to admit that for just having a $6 offering, SP is doing well.

$BLUE Once the offering closes BLUE will be in its strongest position ever.

The offering has made BLUE stronger and more valuable in the long run.

Also being in ARDX and the following day wake up to their offering 🤣🤦‍♂️🤷🏽‍♂️

$FULC is much better and will trade well below $13 offering price

This offering was an unexpected surprise

$BLUE Every indication from the company was that they would go it alone, with the proceeds of this offering they will be much more viable to achieve success and a good return for shareholders in the long-term.